These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22121261)

  • 1. Tumor necrosis factor-alpha in patients with alopecia areata.
    Kasumagic-Halilovic E; Prohic A; Cavaljuga S
    Indian J Dermatol; 2011; 56(5):494-6. PubMed ID: 22121261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma in alopecia areata.
    Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
    Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of total immunoglobulin e in patients with alopecia areata: relationship with clinical type of the disease.
    Kasumagić-Halilović E; Prohić A
    Acta Dermatovenerol Croat; 2006; 14(3):149-52. PubMed ID: 17010262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of interferon-gamma (IFN-g) in patients with alopecia areata: correlation with clinical type and duration of the disease.
    Kasumagic-Halilovic E; Prohic A; Karamehic J
    Med Arh; 2010; 64(4):212-4. PubMed ID: 21246917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-15 and Tumor Necrosis Factor-
    Kamil ZA; Abdullah GA; Zalzala HH
    Dermatol Res Pract; 2023; 2023():5109772. PubMed ID: 37206670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease.
    Kasumagić-Halilovic E; Cavaljuga S; Ovcina-Kurtovic N; Zecevic L
    Skin Appendage Disord; 2018 Oct; 4(4):286-290. PubMed ID: 30410898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA; Youssef N; Bayoumy NM
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.
    Uzuncakmak TK; Engin B; Serdaroglu S; Tuzun Y
    Skin Appendage Disord; 2021 Jan; 7(1):8-12. PubMed ID: 33614711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
    Mostaghimi A; Gandhi K; Done N; Ray M; Gao W; Carley C; Wang T; Swallow E; Sikirica V
    J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
    Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
    JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata.
    Yousefi M; Namazi MR; Rahimi H; Younespour S; Ehsani AH; Shakoei S
    Indian J Dermatol; 2014 Nov; 59(6):630. PubMed ID: 25484412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.
    Bain KA; McDonald E; Moffat F; Tutino M; Castelino M; Barton A; Cavanagh J; Ijaz UZ; Siebert S; McInnes IB; Astrand A; Holmes S; Milling SWF
    Br J Dermatol; 2020 Jan; 182(1):130-137. PubMed ID: 30980732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis.
    Rasheed Z; Alzolibani AA; Al-Shobaili HA; Saif GB; Al Robaee AA
    Immunol Lett; 2014 Jul; 160(1):50-57. PubMed ID: 24694751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata: autoimmune basis of hair loss.
    Alexis AF; Dudda-Subramanya R; Sinha AA
    Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the Risk of Alopecia Areata Progressing to Alopecia Totalis and Alopecia Universalis: Biomarker Development with Bioinformatics Analysis and Machine Learning.
    Zhang T; Nie Y
    Dermatology; 2022; 238(2):386-396. PubMed ID: 34004600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon-gamma and neopterin in alopecia areata].
    Lortkipanidze NT; Tevzadze MSh; Kamkamidze GK
    Georgian Med News; 2005 Jun; (123):53-7. PubMed ID: 16052058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Tumor Necrosis Factor-alpha in Nonlesional Tissues of Alopecia Areata Patients: A Prove for a Systemic Disease.
    Gohary YM; Abdel Fattah DS
    Int J Trichology; 2017; 9(4):154-159. PubMed ID: 29118519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss.
    Serarslan G; Özcan O; Okyay E; Ünlü B; Karadağ M
    Ir J Med Sci; 2021 Aug; 190(3):1015-1020. PubMed ID: 33083959
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.